Genitourinary Cancer
Conference Coverage
Adjuvant nivolumab as standard of care in resected bladder cancer
Compared with placebo, nivolumab improves disease-free survival, nonurothelial tract recurrence-free survival, and distant metastasis-free...
Conference Coverage
Rucaparib benefit in BRCA+ prostate cancer confirmed
New study finding provides evidence of clinical benefit for an indication for rucaparib that was granted an accelerated approval in May 2020.
Latest News
Key factors predict gallbladder cancer on routine cholecystectomy
Identifying predictors allows surgeons to send high-risk individuals for oncologic evaluation beforehand and to prepare for intraoperative frozen...
News
New cancer data spark outcry from patient advocates
The American Cancer Society on Jan. 13 revealed what it called ‘alarming’ news about prostate cancer.
Latest News
People with cancer should be wary of taking dietary supplements
Many patients still think over-the-counter vitamins, minerals, or herbal remedies will help.
Opinion
Oncologists may be too quick to refer patients to palliative care
Integrating palliative care into routine cancer care need not always require a specialty palliative care nurse.
News
‘Low-value’ prostate cancer screening prevalent in primary care
A new study shows that testing for prostate-specific antigen and also digital rectal examinations are both carried out frequently in older men.
News
Atezolizumab (Tecentriq) bladder cancer indication withdrawn in United States
The anti-PD-L1 inhibitor continues to be approved for lung and liver cancers and melanoma.
News
$38,398 for a single shot of a very old cancer drug
The first issue is unrelenting price increases on old drugs that have remained branded as manufacturers find ways to extend patents for decades...
News
Is early-onset cancer an emerging global epidemic?
“This paper ... brings to light the importance of correctable lifestyle habits that may slow the rise of early onset cancers.”